Literature DB >> 581653

Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.

P Dandona, N J Marshall, S P Bidey, A Nathan, C W Havard.   

Abstract

A patient with Graves's disease with acute progressive exophthalmos and pretibial myxoedema was treated twice with plasmapheresis. Two weeks after the first treatment the symptoms recurred, but 20 weeks after the second treatment the exophthalmos was much improved and the pretibial myxoedema had disappeared. Analysis of sequential serum IgG concentrations and the thyroid-stimulating immunoglobulin index suggested that the two conditions were caused by specific IgGs. The results suggest that plasmapheresis has a useful place in the treatment of acute and rapidly progressive ophthalmopathy and pretibial myxoedema in patients with Graves's disease.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 581653      PMCID： PMC1597937          DOI： 10.1136/bmj.1.6160.374

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  10 in total

1.  Binding of thyrotropin to receptors in fat tissue.

Authors:  D L Gill; N J Marshall; R P Ekins
Journal:  Mol Cell Endocrinol       Date:  1978 Feb-Mar       Impact factor: 4.102

2.  Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?

Authors:  H Schleusener; R Finke; P Kotulla; K W Wenzel; H Meinhold; H D Roedler
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

3.  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.

Authors:  P C Dau; J M Lindstrom; C K Cassel; E H Denys; E E Shev; L E Spitler
Journal:  N Engl J Med       Date:  1977-11-24       Impact factor: 91.245

4.  Plasma exchange in the treatment of immune disease.

Authors:  R F Branda; C F Moldow; J J McCullough; H S Jacob
Journal:  Transfusion       Date:  1975 Nov-Dec       Impact factor: 3.157

5.  Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.

Authors:  C M Lockwood; A J Rees; T A Pearson; D J Evans; D K Peters; C B Wilson
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

6.  The binding of ( 3 H)thyrotropin and an 3 H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue.

Authors:  R J Winand; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

7.  Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.

Authors:  E D Mukhtar; B R Smith; G A Pyle; R Hall; P Vice
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

8.  Remission of myasthenia gravis following plasma-exchange.

Authors:  A J Pinching; D K Peters
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

9.  Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?

Authors:  R S Brown; I M Jackson; S L Pohl; S Reichlin
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

10.  Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion.

Authors:  J C Bystryn; M W Graf; J W Uhr
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307
  10 in total
  20 in total

1.  Emergency laparotomy in uncontrolled thyrotoxic patient with preoperative fulminant hepatic failure.

Authors:  S Kiyama; T Yoshikawa; H Ozawa; H Koh; H Maki; K Tsuzaki; K Fukushima
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

2.  Localized myxedema on the nasal dorsum in a patient with Graves' disease: report of a case.

Authors:  F Akasu; K Takazawa; R Akasu; T Onaya
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

Review 3.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

4.  Methylprednisolone and Graves' ophthalmopathy.

Authors:  P Dandona; C W Havard; A Mier
Journal:  BMJ       Date:  1989-03-25

5.  Progress in endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1979-04-14

6.  Orbital decompression for severe dysthyroid eye disease.

Authors:  P Fells
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

7.  The effects of plasma from patients with Graves' disease on foetal mouse hearts in organ culture.

Authors:  A W Nathan; D B Longmore; C W Havard; P Dandona
Journal:  Br J Exp Pathol       Date:  1983-10

8.  Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.

Authors:  C A Hardisty; A Fowles; D S Munro
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

9.  Plasmapheresis in pediatric practice.

Authors:  A Nanu; S K Sood
Journal:  Indian J Pediatr       Date:  1983 Mar-Apr       Impact factor: 1.967

Review 10.  Hypothyroid Graves' disease complicated with elephantiasis nostras verrucosa (ENV): a case report and review of the literature.

Authors:  Kubilay Ukinç; Miyase Bayraktar; Arzu Gedik
Journal:  Endocrine       Date:  2009-04-24       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.